Janda Kim 4
4 · Sorrento Therapeutics, Inc. · Filed Dec 27, 2021
Insider Transaction Report
Form 4
Janda Kim
Director
Transactions
- Sale
Common Stock
2021-12-27$5.88/sh−3,000$17,640→ 3,000 total - Exercise/Conversion
Non-qualified stock option
2021-12-27−3,000→ 0 totalExercise: $4.00From: 2013-01-01Exp: 2022-02-06→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2021-12-27$4.00/sh+3,000$12,000→ 6,000 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.